Transfer of conventional NRP1+ Th cells enhances autoimmune disease and NRP1‐targeting treatment (RPA peptide) significantly ameliorated autoimmune indicators, thus not only are NRP1‐expressing conventional Th cells pathogenic and sufficient to induce disease but also are required for the full establishment of disease. This evidence concerns the gene NRP1 and autoimmune disease.